keyword
https://read.qxmd.com/read/38648082/kinesin-facilitates-phenotypic-targeting-of-therapeutic-resistance-in-advanced-prostate-cancer
#1
JOURNAL ARTICLE
Maddison Archer, Diane Begemann, Edgar Gonzalez-Kozlova, Prerna R Nepali, Estefania Labanca, Peter Shepherd, Navneet Dogra, Nora Navone, Natasha Kyprianou
Understanding the mechanisms underlying resistance is critical to improving therapeutic outcomes in patients with metastatic castration-resistant prostate cancer (mCRPC). Previous work showed dynamic interconversions between epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) defines the phenotypic landscape of prostate tumors, as a potential driver of emergence of therapeutic resistance. In this study, we use in vitro and in vivo preclinical MDA PCa PDX models of resistant human prostate cancer to determine molecular mechanisms of cross-resistance between anti-androgen therapy and taxane chemotherapy, underlying the therapeutically resistant phenotype...
April 22, 2024: Molecular Cancer Research: MCR
https://read.qxmd.com/read/38647957/gut-microbes-in-polycystic-ovary-syndrome-and-associated-comorbidities-type-2-diabetes-non-alcoholic-fatty-liver-disease-nafld-cardiovascular-disease-cvd-and-the-potential-of-microbial-therapeutics
#2
REVIEW
Vineet Singh, Kanika Mahra, DaRyung Jung, Jae-Ho Shin
Polycystic ovary syndrome (PCOS) is one of the most common endocrine anomalies among females of reproductive age, highlighted by hyperandrogenism. PCOS is multifactorial as it can be associated with obesity, insulin resistance, low-grade chronic inflammation, and dyslipidemia. PCOS also leads to dysbiosis by lowering microbial diversity and beneficial microbes, such as Faecalibacterium, Roseburia, Akkermenisa, and Bifidobacterium, and by causing a higher load of opportunistic pathogens, such as Escherichia/Shigella, Fusobacterium, Bilophila, and Sutterella...
April 22, 2024: Probiotics and Antimicrobial Proteins
https://read.qxmd.com/read/38646643/exploring-the-role-of-combined-external-beam-radiotherapy-and-targeted-radioligand-therapy-with-177-lu-lu-psma-617-for-prostate-cancer-from-bench-to-bedside
#3
JOURNAL ARTICLE
Daria Arbuznikova, Aikaterini Klotsotyra, Lisa Uhlmann, Lisa-Charlotte Domogalla, Nils Steinacker, Michael Mix, Gabriele Niedermann, Simon K B Spohn, Martin T Freitag, Anca L Grosu, Philipp T Meyer, Christian Gratzke, Matthias Eder, Constantinos Zamboglou, Ann-Christin Eder
Management of prostate cancer (PC) might be improved by combining external beam radiotherapy (EBRT) and prostate-specific membrane antigen (PSMA)-targeted radioligand therapy (RLT) with lutetium-177 (177 Lu)-labeled PSMA inhibitors. We hypothesized a higher efficacy of the combination due to augmentation of the radiation dose to the tumor and interactions of EBRT with PSMA expression potentially increasing radiopharmaceutical uptake. Therefore, this study analyzed the influence of radiation on PSMA expression levels in vitro ...
2024: Theranostics
https://read.qxmd.com/read/38646169/cancer-associated-fibroblasts-promote-enzalutamide-resistance-and-pd-l1-expression-in-prostate-cancer-through-ccl5-ccr5-paracrine-axis
#4
JOURNAL ARTICLE
Zhi Xiong, Shun-Li Yu, Zhao-Xiang Xie, Rui-Lin Zhuang, Shi-Rong Peng, Qiong Wang, Ze Gao, Bing-Heng Li, Jun-Jia Xie, Hai Huang, Kai-Wen Li
Cancer-associated fibroblasts (CAFs) have been shown to play a key role in prostate cancer treatment resistance, but the role of CAFs in the initial course of enzalutamide therapy for prostate cancer remains unclear. Our research revealed that CAFs secrete CCL5, which promotes the upregulation of androgen receptor (AR) expression in prostate cancer cells, leading to resistance to enzalutamide therapy. Furthermore, CCL5 also enhances the expression of tumor programmed death-ligand 1 (PD-L1), resulting in immune escape...
May 17, 2024: IScience
https://read.qxmd.com/read/38645737/periocular-sebaceous-carcinoma-a-case-audit-from-the-national-specialist-ophthalmic-pathology-service-in-liverpool-from-2009-to-2022-to-assess-the-diagnostic-utility-of-prame-expression
#5
JOURNAL ARTICLE
Amizatul Aini Salleh, Yamini Krishna, Sarah E Coupland
INTRODUCTION: Periocular sebaceous carcinoma (PSC) remains a common diagnostic pitfall both clinically and histomorphologically. PRAME (preferentially expressed antigen in melanoma) has been studied in the various neoplasms as proposed as diagnostic and therapeutic markers. PRAME is expressed in normal sebaceous units and in some sebaceous lesions; however, its utility in sebaceous carcinoma diagnosis has not yet been extensively investigated. We conducted a 13-year retrospective review of the patients diagnosed with PSC at the National Specialist Ophthalmic Pathology Service in Liverpool...
April 2024: Ocular Oncology and Pathology
https://read.qxmd.com/read/38645223/the-neuroendocrine-transition-in-prostate-cancer-is-dynamic-and-dependent-on-ascl1
#6
Rodrigo Romero, Tinyi Chu, Tania J González-Robles, Perianne Smith, Yubin Xie, Harmanpreet Kaur, Sara Yoder, Huiyong Zhao, Chenyi Mao, Wenfei Kang, Maria V Pulina, Kayla E Lawrence, Anuradha Gopalan, Samir Zaidi, Kwangmin Yoo, Jungmin Choi, Ning Fan, Olivia Gerstner, Wouter R Karthaus, Elisa DeStanchina, Kelly V Ruggles, Peter M K Westcott, Ronan Chaligné, Dana Pe'er, Charles L Sawyers
Lineage plasticity is a recognized hallmark of cancer progression that can shape therapy outcomes. The underlying cellular and molecular mechanisms mediating lineage plasticity remain poorly understood. Here, we describe a versatile in vivo platform to identify and interrogate the molecular determinants of neuroendocrine lineage transformation at different stages of prostate cancer progression. Adenocarcinomas reliably develop following orthotopic transplantation of primary mouse prostate organoids acutely engineered with human-relevant driver alterations (e...
April 11, 2024: bioRxiv
https://read.qxmd.com/read/38645121/phthalates-are-detected-in-the-follicular-fluid-of-adolescents-and-oocyte-donors-with-associated-changes-in-the-cumulus-cell-transcriptome
#7
Dilan Gokyer, Mary J Laws, Anna Kleinhans, Joan K Riley, Jodi A Flaws, Elnur Babayev
PURPOSE: To investigate follicular fluid (FF) phthalate levels in adolescents undergoing fertility preservation compared to oocyte donors and explore its association with ovarian reserve and cumulus cell gene expression. METHODS: 20 Adolescents (16.7 ± 0.6 years old) and 24 oocyte donors (26.2 ± 0.4 years old) undergoing fertility preservation were included in the study. Patient demographics, ovarian stimulation and oocyte retrieval outcomes were analyzed for each group...
April 8, 2024: bioRxiv
https://read.qxmd.com/read/38645034/single-cell-analysis-of-treatment-resistant-prostate-cancer-implications-of-cell-state-changes-for-cell-surface-antigen-targeted-therapies
#8
Samir Zaidi, Jooyoung Park, Joseph M Chan, Martine P Roudier, Jimmy L Zhao, Anuradha Gopalan, Kristine M Wadosky, Radhika A Patel, Erolcan Sayar, Wouter R Karthaus, D Henry Kates, Ojasvi Chaudhary, Tianhao Xu, Ignas Masilionis, Linas Mazutis, Ronan Chaligné, Aleksandar Obradovic, Irina Linkov, Afsar Barlas, Achim Jungbluth, Natasha Rekhtman, Joachim Silber, Katia Manova-Todorova, Philip A Watson, Lawrence D True, Colm M Morrissey, Howard I Scher, Dana Rathkopf, Michael J Morris, David W Goodrich, Jungmin Choi, Peter S Nelson, Michael C Haffner, Charles L Sawyers
UNLABELLED: Targeting cell surface molecules using radioligand and antibody-based therapies has yielded considerable success across cancers. However, it remains unclear how the expression of putative lineage markers, particularly cell surface molecules, varies in the process of lineage plasticity, wherein tumor cells alter their identity and acquire new oncogenic properties. A notable example of lineage plasticity is the transformation of prostate adenocarcinoma (PRAD) to neuroendocrine prostate cancer (NEPC)--a growing resistance mechanism that results in the loss of responsiveness to androgen blockade and portends dismal patient survival...
April 12, 2024: bioRxiv
https://read.qxmd.com/read/38644435/in-situ-fabrication-of-covalent-organic-frameworks-on-solid-phase-microextraction-probes-coupled-with-electrospray-ionization-mass-spectrometry-for-enrichment-and-determination-of-androgens-in-biosamples
#9
JOURNAL ARTICLE
Heming Li, Yuxin Tu, Wen Xie, Xinye Shi, Qiuting Zhang, Juan Lin, Yanhui Zhong, Zian Lin, Zongwei Cai
Solid-phase microextraction (SPME) coupled with electrospray ionization mass spectrometry (ESI-MS) was developed for rapid and sensitive determination of endogenous androgens. The SPME probe is coated with covalent organic frameworks (COFs) synthesized by reacting 1,3,5-tri(4-aminophenyl)benzene (TPB) with 2,5-dioctyloxybenzaldehyde (C8PDA). This COFs-SPME probe offers several advantages, including enhanced extraction efficiency and stability. The analytical method exhibited wide linearity (0.1-100.0 µg L-1 ), low limits of detection (0...
April 22, 2024: Mikrochimica Acta
https://read.qxmd.com/read/38644146/deep-and-durable-prostate-specific-antigen-response-to-darolutamide-with-androgen-deprivation-therapy-and-docetaxel-and-association-with-clinical-outcomes-for-patients-with-high-or-low-volume-metastatic-hormone-sensitive-prostate-cancer-analyses-of-the-randomized
#10
JOURNAL ARTICLE
Fred Saad, Maha H A Hussain, Bertrand Tombal, Karim Fizazi, Cora N Sternberg, E David Crawford, Luke T Nordquist, Martin Bögemann, Ronald Tutrone, Neal D Shore, Laurence Belkoff, Todd Fralich, Jay Jhaveri, Shankar Srinivasan, Rui Li, Frank Verholen, Iris Kuss, Matthew R Smith
BACKGROUND AND OBJECTIVE: Addition of darolutamide to androgen deprivation therapy (ADT) and docetaxel significantly improved overall survival (OS) in ARASENS (NCT02799602). Here we report on prostate-specific antigen (PSA) responses and their association with outcomes. METHODS: ARASENS is an international, double-blind, phase 3 study in patients with metastatic hormone-sensitive prostate cancer (mHSPC) randomized to darolutamide 600 mg orally twice daily (n = 651) or placebo (n = 654), both with ADT + docetaxel...
April 20, 2024: European Urology
https://read.qxmd.com/read/38643973/methylation-of-phase-ii-metabolites-of-endogenous-anabolic-androgenic-steroids-to-improve-analytical-performance
#11
JOURNAL ARTICLE
Sandra Pfeffer, Guenter Gmeiner, Guro Forsdahl
The study of intact phase II metabolites of endogenous anabolic androgenic steroids (EAAS) gives important information about metabolism and has the potential to improve the detection of doping with testosterone. For analysis with liquid chromatography-mass spectrometry (LC-MS), chemical derivatization at the steroid moiety is a technique to improve the positive ionization efficiency of glucuronidated/sulfated EAAS under collision-induced dissociation (CID) conditions. However, regarding the chromatographic performance, there are still challenges to address, for example, poor peak shape, which is mainly caused by nondefined adsorption in the chromatographic system...
April 21, 2024: Drug Testing and Analysis
https://read.qxmd.com/read/38643863/revealing-the-mechanism-of-ethyl-acetate-extracts-of-semen-impatientis-against-prostate-cancer-based-on-network-pharmacology-and-transcriptomics
#12
JOURNAL ARTICLE
Bintao Hu, Chengwei Wang, Yue Wu, Chenglin Han, Jihong Liu, Ruibao Chen, Tao Wang
ETHNOPHARMACOLOGICAL RELEVANCE: Prostate cancer (PCa) is the most common malignancy of the male genitourinary system and currently lacks effective treatment. Semen Impatientis, the dried ripe seed of Impatiens balsamina L., is described by the Chinese Pharmacopoeia as a traditional Chinese medicine (TCM) and is used in clinical practice to treat tumors, abdominal masses, etc. In our previous study, the ethyl acetate extracts of Semen Impatientis (EAESI) was demonstrated to be the most effective extract against PCa among various extracts...
April 19, 2024: Journal of Ethnopharmacology
https://read.qxmd.com/read/38643469/aat-resistance-related-ac007405-2-and-al354989-1-as-novel-diagnostic-and-prognostic-markers-in-prostate-cancer
#13
JOURNAL ARTICLE
Yuanzhong Deng, Chunlin Zhang, Haitao Yu, Guo Chen, Xiang Peng, Yang Li, Zhenwei Feng, Wei Shi, Xuesong Bai, Xin Gou, Nian Liu
OBJECTIVE: Prostate cancer (PCa) is the second disease threatening men's health, and anti-androgen therapy (AAT) is a primary approach for treating this condition. Increasing evidence suggests that long non-coding RNAs (lncRNAs) play crucial roles in the development of PCa and the process of AAT resistance. The objective of this study is to utilize bioinformatics methods to excavate lncRNAs association with AAT resistance and investigate their biological functions. METHODS: AAT resistance-related risk score model (ARR-RSM) was established by multivariate Cox analysis...
April 19, 2024: Aging
https://read.qxmd.com/read/38643322/sarcopenic-obesity-and-reduced-bmd-in-young-men-living-with-hiv-body-composition-and-sex-steroids-interplay
#14
JOURNAL ARTICLE
S De Vincentis, C Greco, F Fanelli, M C Decaroli, C Diazzi, M Mezzullo, J Milic, M C De Santis, L Roli, U Pagotto, G Guaraldi, V Rochira
PURPOSE: Sex steroids play a key role on male bone homeostasis and body composition (BC), their role in men living with HIV (MLWH) is less recognized. This study aimed at investigating the prevalence of low BMD, sarcopenia, and sarcopenic obesity (SO) and their relationship with sex steroids in MLWH aged < 50. METHODS: Prospective, cross-sectional, observational study on MLWH younger than 50 (median age 47.0 years). BC and BMD were evaluated with DXA...
April 20, 2024: Journal of Endocrinological Investigation
https://read.qxmd.com/read/38643196/apigetrin-ameliorates-doxorubicin-prompted-testicular-damage-biochemical-spermatological-and-histological-based-study
#15
JOURNAL ARTICLE
Muhammad Umar Ijaz, Saba Yaqoob, Ali Hamza, Mehwish David, Tayyaba Afsar, Fohad Mabood Husain, Houda Amor, Suhail Razak
Doxorubicin (DOX) is a highly effective, commonly prescribed, potent anti-neoplastic drug that damages the testicular tissues and leads to infertility. Apigetrin (APG) is an important flavonoid that shows diverse biological activities. The present research was designed to evaluate the alleviative role of APG against DOX-induced testicular damages in rats. Forty-eight adult male albino rats were randomly distributed into 4 groups, control, DOX administered (3 mgkg-1 ), DOX + APG co-administered (3 mgkg-1 of DOX; 15 mgkg-1 of APG), and APG administered group (15 mgkg-1 )...
April 20, 2024: Scientific Reports
https://read.qxmd.com/read/38642866/neurobiology-of-social-interactions-across-species-role-of-neuroestrogens-in-the-regulation-of-social-behaviors-from-social-recognition-to-mating
#16
REVIEW
Dario Aspesi, Charlotte A Cornil
In this mini-review, we summarize the brain distribution of aromatase, the enzyme catalyzing the synthesis of estrogens from androgens, and the mechanisms responsible for regulating estrogen production within the brain. Understanding this local synthesis of estrogens by neurons is pivotal as it profoundly influences various facets of social behavior. Neuroestrogen action spans from the initial processing of socially pertinent sensory cues to integrating this information with an individual's internal state, ultimately resulting in the manifestation of either pro-affiliative or - aggressive behaviors...
April 18, 2024: Neuroscience and Biobehavioral Reviews
https://read.qxmd.com/read/38642459/optimizing-outcomes-in-men-with-prostate-cancer-the-cardiovascular-event-lowering-caelo-pathways
#17
JOURNAL ARTICLE
David E Crawford, David Albala, Marc B Garnick, Andrew W Hahn, Paul Maroni, Rana R McKay, Martin Miner, Peter Orio Ⅲ, Kshitij Pandit, Scott Sellinger, Evan Y Yu, Robert H Eckel
INTRODUCTION: Risk of cardiovascular disease is higher among men with prostate cancer than men without, and prostate cancer treatments (especially those that are hormonally based) are associated with increased cardiovascular risk. MATERIALS AND METHODS: An 11-member panel of urologic, medical, and radiation oncologists (along with a men's health specialist and an endocrinologist/preventive cardiologist) met to discuss current practices and challenges in the management of cardiovascular risk in prostate cancer patients who are taking androgen deprivation therapies (ADT) including LHRH analogues, alone and in combination with androgen-targeted therapies (ATTs)...
April 2024: Canadian Journal of Urology
https://read.qxmd.com/read/38642173/psychosocial-factors-associated-with-cognitive-function-in-prostate-cancer-survivors-on-hormonal-treatments-a-systematic-review
#18
REVIEW
Lorna Pembroke, Kerry A Sherman, Heather Francis, Haryana M Dhillon, Howard Gurney, David Gillatt
Hormonal treatments (HT) for prostate cancer (e.g., androgen deprivation therapy) yield clinical and survival benefits, yet adverse cognitive changes may be a side effect. Since psychosocial factors are largely modifiable, interventions targeting these factors may help mitigate these adverse cognitive effects. This systematic review aimed to identify a range of psychosocial factors associated with cognitive function in individuals with prostate cancer undergoing HT and to determine whether these factors mitigate or exacerbate this effect...
April 20, 2024: Neuropsychology Review
https://read.qxmd.com/read/38642125/surgical-management-of-rectal-cancer-with-synchronous-treatment-of-prostate-cancer
#19
JOURNAL ARTICLE
Raphaëlle Brière, André-Guy Martin, François Letarte, François Rouleau Fournier, Philippe Bouchard, Sébastien Drolet
PURPOSE: To assess the safety and efficacy of synchronous treatments for rectal (RC) and prostate (PC) cancers. METHODS: Single-center retrospective study (2007-2021) of patients treated with neoadjuvant radiotherapy (RT) and total mesorectal excision (TME) for RC with synchronous PC treatment. The endpoints were 30-day postoperative severe complications, R0 resection rates, 3-year disease-free survival (DFS) and 3-year overall survival (OS). RESULTS: Among the 16 patients, 15 (93...
April 20, 2024: Langenbeck's Archives of Surgery
https://read.qxmd.com/read/38641716/qualitative-interviews-of-patients-with-copd-and-muscle-weakness-enrolled-in-a-clinical-trial-evaluating-a-new-anabolic-treatment-patient-perspectives-of-disease-experience-trial-participation-and-outcome-assessments
#20
JOURNAL ARTICLE
Maggie Tabberer, Nicola Williamson, Sophi Tatlock, Adam Gater, Rebecca Grimes, Chika Akinseye, David Neil, Aoife Mahon-Smith, Linda Nelsen
BACKGROUND: Chronic obstructive pulmonary disease (COPD) and muscle weakness can cause impaired physical function, significantly impacting patients' health-related quality of life (HRQoL). Loss of muscle strength is usually assessed through clinical and performance outcome (PerfO) assessments, which consists of tasks performed in a standardized manner, providing evidence of a patient's functional ability. However, evidence documenting the patient experience of COPD and muscle weakness is limited...
April 20, 2024: Journal of Patient-Reported Outcomes
keyword
keyword
13258
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.